Financial insights of VCNX

MyFinsight

For the quarter ending 2024-09-30, VCNX made $52K in revenue. -$5,732K in net income. Net profit margin of -11023.08%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-09-30
Revenue from contract with customer, excluding assessed tax	52
Research and development expense	3,165
General and administrative expense	1,439
Costs and expenses	4,604
Operating income (loss)	-4,552
Loss on settlement of warrants	-1,106
Change in fair value of warrant liabilities	71
Other nonoperating income (expense)	-3
Income (loss) from continuing operations before income taxes, noncontrolling interest	-5,732
Net loss attributable to vaccinex, inc. common stockholders	-5,732

Basic eps	-2.83
Diluted eps	-2.83
Basic average shares	2,026,920
Diluted average shares	2,026,920

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-09-30
Revenue from contract with customer, excluding assessed tax	52
Research and development expense	3,165
General and administrative expense	1,439
Costs and expenses	4,604
Operating income (loss)	-4,552
Loss on settlement of warrants	-1,106
Change in fair value of warrant liabilities	71
Other nonoperating income (expense)	-3
Income (loss) from continuing operations before income taxes, noncontrolling interest	-5,732
Net loss attributable to vaccinex, inc. common stockholders	-5,732

Basic eps	-2.83
Diluted eps	-2.83
Basic average shares	2,026,920
Diluted average shares	2,026,920

Financial insights of VCNX